Insights Articles
Article
HHS-OIG Issues Guidance on Pharma DTC Prescription Drug Sales, but Key Legal Questions Remain
May 1, 2026
| Journal of Health Care Compliance
Authors:
Person Brian Bohnenkamp
Brian A. Bohnenkamp
Partner
Person Robert DeConti
Robert K. DeConti (Rob)
Partner
Person Seth Lundy
Seth H. Lundy
Partner
Person Kelly Reeves
Nikki Reeves
Partner
Person John Shakow
John D. Shakow
Partner
Person Christina Markus
Christina M. Markus (Chris)
Partner

Go to the article

Authors
Person Brian Bohnenkamp
Brian A. Bohnenkamp
Partner
Government Matters & Regulation
Person Robert DeConti
Robert K. DeConti (Rob)
Partner
Government Matters & Regulation
Person Seth Lundy
Seth H. Lundy
Partner
Government Matters & Regulation
Person Kelly Reeves
Nikki Reeves
Partner
Government Matters & Regulation
Person John Shakow
John D. Shakow
Partner
Government Matters & Regulation
Person Christina Markus
Christina M. Markus (Chris)
Partner
Government Matters & Regulation
Person Kalle Deyette
Kalle E. Deyette
Senior Associate
Government Matters & Regulation
Related Capabilities
FDA & Life Sciences
Explore King & Spalding
a blue and green background
Capabilities
FDA & Life Sciences
Learn More

The Best and Latest Insights
All in One Place.

Subscribe